$1.33
-0.01-0.75%
Last update: Nov 4, 8:54 AM
Zhengye Biotechnology Holding Ltd (ZYBT) Stock Price, Quote, News & History
ZYBTNASDAQ
Zhengye Biotechnology stock plunges after a 322% rally as the company finds no undisclosed catalyst and contacts Nasdaq.
You can purchase shares of Zhengye Biotechnology (NASDAQ:ZYBT) through any online brokerage.
Other companies in Zhengye Biotechnology’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
There is no analysis for Zhengye Biotechnology to provide a consensus price target.
The stock price for Zhengye Biotechnology (NASDAQ: ZYBT) is $1.33 last updated November 4, 2026 at 8:54 AM EST.
There are no upcoming dividends for Zhengye Biotechnology.
Zhengye Biotechnology does not have any upcoming earnings scheduled.
There is no upcoming split for Zhengye Biotechnology.
Zhengye Biotechnology is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats,...
